Skip to main content
  • En
  • Français

Top Navigation

  • Newsroom
  • Contact Us

Main navigation

  • About Us
  • Products
  • Clinical Studies
  • Investors
  • Obligations convertibles
    • Documents liés à l'émission et à la conversion d'obligations convertibles
    • Nouveau dénominateur en date du 28 avril 2026
    • Nouveau dénominateur en date du 08 mai 2025
  • News
  • En
  • Français

English version is not updated since 2025-01-01.

Extraordinary General Meeting

Thu, 08/05/2021 - 12:00
Minutes of the Extraordinary General Meeting (FR)461.68 KB
Notice449.16 KB
Proxy668.11 KB
Shareholders' rights pursuant to art. 7:130 and 7:139 of the Belgian Companies Code418.56 KB
Special Report of Board of Directors pursuant to art. 7:180, 7:191 and 7:193 of the Belgian Companies Code (FR)717.33 KB
Special Report of Board of Directors pursuant to art. 7:228 and 7:229 of the Belgian Companies Code (FR)730.05 KB
Auditor's report pursuant to art. 7:180, 7:191 and 7:193 of the Belgian Companies Code (FR)688.63 KB
EIB Finance Contract5.46 MB
EIB Warrant Agreement1.39 MB
Year
2021
Financial Information
Annual General Meeting
Shareholder information
Shareholder meetings
Wallonie Eu Flag

BioSenic SA
Avenue Léon champagne, 3
1480 Saintes – Belgium
info@biosenic.com
 

Sign upfor our press releases

Receive information about BioSenic

Sign Up

Footer menu

  • Privacy Policy
  • Trademarks Copyrights
  • Users conditions